The lncRNA LINC00691 Functions as a ceRNA for miRNA-1256 to Suppress Osteosarcoma by Regulating the Expression of ST5
Open Access
- 1 December 2020
- journal article
- research article
- Published by Taylor & Francis Ltd in OncoTargets and Therapy
- Vol. ume 13, 13171-13181
- https://doi.org/10.2147/ott.s266435
Abstract
Introduction: Osteosarcoma is the most common primary malignant tumor in children and young patients. Although neoadjuvant chemotherapy and surgery could improve the prognosis of these patients, treatment outcomes are poor because of its low early diagnosis rate and high degree of malignancy as well as its tendency for early metastasis. In the field of osteosarcoma, lncRNAs have become a hot spot for studying the molecular mechanisms driving malignant biological characteristics and exploring effective treatment methods. An lncRNA is a long noncoding RNA lacking protein-encoding ability, and in its RNA form, it regulates various gene expression processes, such as epigenetic regulation, transcriptional regulation, and posttranscriptional regulation. LncRNAs play an important role in tumorigenesis and metastasis. Methods: We used bioinformatics software to analyze the data in geo database. CCK-8 and Transwell were used to detect the effect of lncRNA LINC00691 on the proliferation and migration of osteosarcoma cells. The target gene of LINC00691 was detected by bioinformatics analysis and RNA pull down. Results: In this study, we identified the lncRNA LINC00691 and confirmed its expression in osteosarcoma cells through GEO database analysis. Expression analysis showed that the levels of lncRNA LINC00691 in osteosarcoma cells were decreased compared to those of control cells. Overexpression of LINC00691 could inhibit the proliferation, migration, invasion, and induction of G1 cell cycle arrest in osteosarcoma cells, which was shown through in vitro and in vivo studies. Using bioinformatics analysis, RNA pull down experiments and luciferase reporter gene detection assays, we found that LINC00691 regulated ST5 expression by binding miR-1256. LINC00691 overexpression inhibited EMT by promoting the expression of E-cadherin and increasing the expression of ZEB1, Snail, and Fibronectin. Conclusion: These results suggested that overexpressed LINC00691 promoted the expression of ST5 by regulating the function of miR-1256 through a ceRNA mechanism. The LINC00691/miR-1256/ST5 pathway plays an important role in the progression and metastasis of osteosarcoma and represents a good therapeutic target.Keywords
This publication has 37 references indexed in Scilit:
- Cancer stem cells in osteosarcomaCancer Letters, 2016
- MALAT1 promotes osteosarcoma development by targeting TGFA via MIR376AOncotarget, 2016
- Screening and validation of lncRNAs and circRNAs as miRNA spongesBriefings in Bioinformatics, 2016
- An update on chemotherapy for osteosarcomaExpert Opinion on Pharmacotherapy, 2015
- Phosphorylation-dependent Regulation of Connecdenn/DENND1 Guanine Nucleotide Exchange FactorsOnline Journal of Public Health Informatics, 2015
- The Immunotherapy of Canine Osteosarcoma: A Historical and Systematic ReviewJournal of Veterinary Internal Medicine, 2015
- Translational biology of osteosarcomaNature Reviews Cancer, 2014
- OsteosarcomaAnnals of Oncology, 2010
- Transfer of a normal human chromosome 11 suppresses tumorigenicity of some but not all tumor cell linesJournal of Cellular Biochemistry, 1990
- The deformability of bhk cells and polyoma virus-transformed bhk cells in relation to locomotory behaviourJournal of Cell Science, 1980